One molecular mark, three kinds of memory
CpG methylation turns up wherever a cell needs to remember something — a synapse that fired, an antigen it fought off, a body that once went through something hard. The same chemistry, a methyl group on a cytosine before a guanine, running three completely different memory systems.
How a synapse writes something down
Methylation was long treated as a developmental lock — set early, then static for the life of the cell. That view does not survive contact with the adult hippocampus, where marks are added and removed within hours of a learning event.
Quotes are short excerpts in the original English, one per source, each linked to the paper. Everything else is a paraphrase.
Rescue of aging-associated decline in Dnmt3a2 expression restores cognitive abilities
“Dnmt3a2 is an activity-regulated immediate early gene”— Oliveira et al., Nat Neurosci 2012
Activity-induced DNA breaks govern the expression of neuronal early-response genes
“DSB formation is a physiological event that rapidly resolves topological constraints”— Madabhushi et al., Cell 2015
Two enzyme families, two directions, at once
DNMT3A adds marks while the TET enzymes (TET1–3) oxidise 5-methylcytosine back toward an unmethylated state. Learning is not methylation going up; it is both families working simultaneously at different loci. That also means hippocampal methylation looks like a short-lived working step in consolidation — a scratchpad — while the more permanent copy is thought to shift to cortex over time. It is one molecular echo of why very old memories survive hippocampal damage and recent ones do not.
The memory your T cells already have
This is the version closest to my own work. A naive CD8⁺ T cell that meets its antigen rewrites large parts of its methylome on the way to becoming an effector — and what happens next depends entirely on whether the antigen ever goes away.
Unwritten
PDCD1 methylated, effector loci closed. Nothing has happened yet.
Filed away
The antigen cleared. Effector-phase demethylation gets reversed — the cell goes back and re-methylates. Poised, not active.
Stuck open
The antigen never cleared. Demethylation locks in and the inhibitory programme becomes constitutive.
Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8⁺ T cells
“Exhausted virus-specific CD8+ T cells retain an unmethylated Pdcd1 regulatory region”— Youngblood et al., Immunity 2011
De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation
“fully exhausted during prolonged antigen exposure remain refractory to ICB-mediated rejuvenation”— Ghoneim et al., Cell 2017
The same lever I pull on CD55
The machinery behind CRISPRoff and ZFPoff — a KRAB repressor fused to a DNMT domain — is mechanistically the same lever a T cell pulls on itself while differentiating. The donor T cells in my Day 6 and Day 35 experiments already carry this history in their methylome before I touch them. Editing CD55 is writing one deliberate mark into a genome that has been writing its own for years.
When an experience becomes a cell
The most interesting and the most contested corner of the field. The claim is not that hardship changes your DNA — the sequence is untouched. It is that psychologically significant experience shifts the methylation state of specific stress-regulatory genes, measurably, decades later.
Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions
“allele-specific, childhood trauma-dependent DNA demethylation”— Klengel et al., Nat Neurosci 2013
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
“increased cytosine methylation of an NR3C1 promoter”— McGowan et al., Nat Neurosci 2009
Reading blood as a proxy for brain
The caveat researchers keep repeating: tissue matters. Whole-blood methylation is a proxy, not a readout of cortex or hippocampus, and for most loci the correspondence between the two is weak. FKBP5 is treated as one of the more defensible cases, which is part of why it keeps appearing in this literature — but a blood measurement is a hypothesis about the brain, not a measurement of it.
Worth holding onto
Most of this literature is correlational and cross-sectional. Effect sizes at individual CpGs are typically small, findings often fail to replicate cleanly across cohorts, and causal direction is genuinely open: does adversity cause the methylation change, does baseline methylation shape vulnerability to adversity, or are both downstream of something else — genotype, earlier stress, current symptoms? Biological embedding is an active research programme, not settled fact at the level of any single gene.
Same mark, same trick, three systems
All three reuse one move: make a transient state durable by writing it into methylation, at a specific locus, in a specific cell type. What differs is how long the writing lasts.
| System | What gets written down | Where | Durability |
|---|---|---|---|
| Hippocampal neuron | A moment of synaptic activity | Fos · Npas4 · Egr1 · IEG promoters | Hours to days — a scratchpad, rewritten constantly |
| Memory T cell | An antigen that was cleared | PDCD1 and effector loci | Years — deliberately reversed, then held poised |
| Exhausted T cell | An antigen that never cleared | PDCD1 regulatory region | Locked — survives antigen clearance and PD-1 blockade |
| HPA axis | A period of adversity, often in childhood | FKBP5 intron 7 · NR3C1 exon 1F | Decades — but apparently still movable |
The open question worth sitting with
What decides whether a mark stays reversible or locks? Hippocampal consolidation is reversible by design. FKBP5 seems to move under therapy. Exhausted-cell PD-1 does not move even when the antigen is gone and the checkpoint is blocked. That is not a neat parallel — it is a mechanistic question about chromatin stability, and it is one my own data speaks to directly: CRISPRoff writes a mark at CD55 on purpose, and nanopore then measures, molecule by molecule, how long it survives. Day 6 versus Day 35 is a durability experiment.
Does any of this reach the next generation? →
Everything above happens in somatic cells within one lifetime. FKBP5 and NR3C1 appear on both pages, but the question there is different: whether a mark survives the germline and shows up in a child who was never exposed. Short answer so far: for methylation, not demonstrated.
Papers referenced on this page
- 1
Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons
- 2
Rescue of aging-associated decline in Dnmt3a2 expression restores cognitive abilities
- 3
Dnmt3a2: a hub for enhancing cognitive functions
- 4
Activity-induced DNA breaks govern the expression of neuronal early-response genes
- 5
Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8⁺ T cells
- 6
De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation
- 7
Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions
- 8
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
- 9
Synaptic control of DNA methylation involves activity-dependent degradation of DNMT3A1 in the nucleus
Last checked August 2026. Open-access links are marked; the rest lead to the publisher's page.